We developed a Western blot assay using purified human c-myc protein expressed in E. coli in order to look for circulating anti-c-myc antibodies in human sera. The presence of IgG antibodies against c-myc was observed in 25 out of 44 sera from patients with colorectal cancer diagnosed and treated at
Presence of circulating anti-c-myb oncogene product antibodies in human sera
✍ Scribed by Irène Sorokine; Kamel Ben-Mahrez; Annie Bracone; Dominique Thierry; Shunsuke Ishii; Fumio Imamoto; Masamichi Kohiyama
- Publisher
- John Wiley and Sons
- Year
- 1991
- Tongue
- French
- Weight
- 575 KB
- Volume
- 47
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Bacterially expressed mouse c-myb protein was purified from E. coliextracts and used as antigen to screen human sera for circulating anti-c-my6 oncogene product antibodies. Using Western blotting, we have found that human sera contain IgG antibodies to the c-my6 gene product. The percentage of positive sera in cancer patients appears to be dependent upon cancer type and is significantly higher in breast-cancer patients than in normal donors: 43% of sera from breast-cancer patients are positive, whereas in neuroblastoma cancer patients the production of IgG anti-c-myb appears to be rare. No significant correlation was observed between the presence of circulating anti-c-myb antibodies and the expression of the c-myb gene in breast tumors.
📜 SIMILAR VOLUMES